ArticleCancer research and treatment2016

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.

Se Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.